Several studies investigating not only BMI but also body fat percentage [10], fatty liver disease [29], glucose tolerance and insulin resistance [30, 31] in HF and non-HF patients, found similar correlations and suppose the amount of adipose tissue to be an important contributing factor in decreasing NT-proBNP levels. Here, NPPB is linked to fatty liver disease.